Obstetric antiphospholipid syndrome: Current uncertainties should guide our way

Lupus

Volumn 19, Issue 4, 2010, Pages 446-452

  Branch, D W ^a   Silver, R M ^a   Porter, T F ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; APL; Fetal death; Lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; GLUCOCORTICOID; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; PHOSPHOLIPID ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG SAFETY; FETUS DEATH; HEALTH CARE PRACTICE; HUMAN; LOW DRUG DOSE; NONHUMAN; PATIENT CARE; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; RECURRENT ABORTION; REPRODUCTION; REVIEW;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL DEATH; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; THROMBOSIS; UNITED STATES;

EID: 77951216439     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310361490     Document Type: Review

References (25)

1. Wilson WA, Gharavi AE, Koike, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999 ; 42: 1309-1311.
2. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
3. Petri M., Golbus M., Anderson R., et al. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum 1987 ; 30: 601-606.
4. Clifford K., Rai R., Watson H., Regan L. Pregnancy: an informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994 ; 9: 1328-1332. (Pubitemid 24224005)
5. Yetman DL, Kutteh WH Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996 ; 66: 540-546.
6. Reznikoff-Etievant MF, Cayol V., Zou GM, et al. Habitual abortions in 678 healthy patients: investigation and prevention. Hum Reprod 1999 ; 14: 2106-2109. (Pubitemid 29381253)
7. Rai RS, Regan L., Clifford K., et al. Antiphospholipid antibodies and beta-2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995 ; 10: 2001-2005.
8. Kutteh WH Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996 ; 174: 1584-1589. (Pubitemid 26165282)
9. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997 ; 314: 253-257. (Pubitemid 27047378)
10. Farquharson RG, Quenby S., Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002 ; 100: 408-413. (Pubitemid 35246124)
11. Laskin CA, Spitzer K., Clark C., et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol 2009 ; 36: 279-287.
12. Salmon JE, Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol 2008 ; 77: 51-56.
13. El Mourabet M., El-hachem S., Harrison JR, Binion DG Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review. Curr Drug Targets 2009 ; [epub ahead of print: DOI: 19916950].
14. Branch DW, Andres R., Digre KB, et al. The association of Antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989 ; 73: 541-545. (Pubitemid 19086960)
15. Pattison NS, Chamley LW, McKay EJ, et al. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993 ; 100: 909-913. (Pubitemid 23308274)
16. Yasuda M., Takakuwa K., Tokunaga A., Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995 ; 86: 555-559.
17. Nodler J., Moolamalla SR, Ledger SM, et al. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth 2009 ; 9: 11-18.
18. Yamada H., Atsumi T., Amengual O., et al. Glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: a case-controlled study. J Reprod Immunol, epub ahead of print.
19. Clark EA, Silver RM, Branch DW Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007 ; 9: 219-225. (Pubitemid 46954780)
20. Dreyfus M., Hedelin G., Kutnahorsky R., et al. Antiphospholipid antibodies and preeclampsia: A case-control study. Obstet Gynecol 2001 ; 97: 29-34. (Pubitemid 32057151)
21. Branch DW, Porter TF, Rittenhouse L., et al. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001 ; 184: 825-832. (Pubitemid 32368100)
22. Lee RM, Brown MA, Branch DW, et al. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 2003 ; 102: 294-300.
23. Lynch A., Marlar R., Murphy J., et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Inten Med 1994 ; 120: 470-475.
24. Katano K., Aoki A., Sasa H., et al. Beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996 ; 11: 509-512. (Pubitemid 26125247)
25. Faden D., Tincani A., Tanzi P., et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 1997 ; 73: 37-42.